We've found
1,348
archived clinical trials in
Podiatry
We've found
1,348
archived clinical trials in
Podiatry
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Updated: 12/31/1969
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Updated: 12/31/1969
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Updated: 12/31/1969
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Updated: 12/31/1969
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
Updated: 12/31/1969
A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
Status: Enrolling
Updated: 12/31/1969
Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
Updated: 12/31/1969
A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
MIRODERM H2H DFU Study
Updated: 12/31/1969
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
Updated: 12/31/1969
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Subjects With Diabetic Foot Ulcer (DFU)
Updated: 12/31/1969
Qualitative Research in Patients With Diabetic Foot Ulcer
Status: Enrolling
Updated: 12/31/1969
Study of Subjects With Diabetic Foot Ulcer (DFU)
Updated: 12/31/1969
Qualitative Research in Patients With Diabetic Foot Ulcer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study Evaluating the Effect of Jublia on Dermatophytomas
Updated: 12/31/1969
An Investigator Initiated Pilot Study Evaluating the Efficacy of Efinaconazole 10% Solution (Jublia) for the Treatment of Onychomycosis With Dermatophytomas
Status: Enrolling
Updated: 12/31/1969
Study Evaluating the Effect of Jublia on Dermatophytomas
Updated: 12/31/1969
An Investigator Initiated Pilot Study Evaluating the Efficacy of Efinaconazole 10% Solution (Jublia) for the Treatment of Onychomycosis With Dermatophytomas
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation Of An Advanced Borderless Dressing
Updated: 12/31/1969
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Evaluation Of An Advanced Borderless Dressing
Updated: 12/31/1969
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation Of An Advanced Borderless Dressing
Updated: 12/31/1969
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Evaluation Of An Advanced Borderless Dressing
Updated: 12/31/1969
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation Of An Advanced Borderless Dressing
Updated: 12/31/1969
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Evaluation Of An Advanced Borderless Dressing
Updated: 12/31/1969
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
Updated: 12/31/1969
An Open-label, Multiple-dose Study Of The Absorption And Systemic Pharmacokinetics Of An2690 Applied As A 7.5% Solution To All Toenails Of Adult Patients With Moderate To Severe Onychomycosis
Status: Enrolling
Updated: 12/31/1969
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
Updated: 12/31/1969
An Open-label, Multiple-dose Study Of The Absorption And Systemic Pharmacokinetics Of An2690 Applied As A 7.5% Solution To All Toenails Of Adult Patients With Moderate To Severe Onychomycosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Updated: 12/31/1969
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Updated: 12/31/1969
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
Updated: 12/31/1969
An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
Updated: 12/31/1969
An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
Updated: 12/31/1969
A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
Updated: 12/31/1969
A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials